Search research articles
Contact Us
Filters
Showing results (361-370 of 380) with videos related to
Page
of 38
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 4, 2014
[CCAFU Recommendations 2013: Upper urinary tract carcinoma]
C Pfister, M Roupret, Y Neuzillet, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia
P Sonneveld, A Burnett, P Vossebeld, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
January 6, 2021
A multicentre cross-sectional descriptive study evaluating the cardiovascular risk profile of preoperatively identified patients with hypertension
S Govender, C Pfister, B Rayner, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
T Seisen, E Compérat, P Colin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
P Gimel, M Gross-Goupil, L Geoffrois, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 25, 2010
[What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU]
D Amsellem-Ouazana, C Theodore, J Irani, et al.
ESMO Open
|
May 17, 2025
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study
T Decker, C Brucker, A Engel, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology
Melissa H Bloodworth, Mark Rusznak, Connor C Pfister, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2008
[Do broader indications for partial nephrectomy result in excess morbidity?]
G Verhoest, M Crepel, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 1, 2011
[Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm]
F Boulière, M Crepel, P Bigot, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 380) with videos related to
Sort By:
Page
of 38
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 4, 2014
[CCAFU Recommendations 2013: Upper urinary tract carcinoma]
C Pfister, M Roupret, Y Neuzillet, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia
P Sonneveld, A Burnett, P Vossebeld, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
January 6, 2021
A multicentre cross-sectional descriptive study evaluating the cardiovascular risk profile of preoperatively identified patients with hypertension
S Govender, C Pfister, B Rayner, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
T Seisen, E Compérat, P Colin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
P Gimel, M Gross-Goupil, L Geoffrois, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 25, 2010
[What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU]
D Amsellem-Ouazana, C Theodore, J Irani, et al.
ESMO Open
|
May 17, 2025
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study
T Decker, C Brucker, A Engel, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology
Melissa H Bloodworth, Mark Rusznak, Connor C Pfister, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2008
[Do broader indications for partial nephrectomy result in excess morbidity?]
G Verhoest, M Crepel, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 1, 2011
[Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm]
F Boulière, M Crepel, P Bigot, et al.
Page
of 38